Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
for the treatment of infectious diseases. As part of the structured doctoral program International Leibniz Research School ILRS 2.0, we invite talented candidates to apply for 9 Doctoral Researcher (m/f/div
-
: Bioinformatician Applications Specialist (Molecular Biology) Both positions are offered at the E13 TVöD-Bund level and will initially be limited to two years, with the possibility of extension or transition to a
-
encourage applications from women and candidates with disabilities, who will be given preference in cases of equal qualification. Appointments are made solely on merit. Contact for Informal Inquiries Prof. Dr
-
Fusobacterium nucleatum Applications are invited for Postdoctoral and PhD positions in the laboratories of Professor Franziska Faber and Professor Jörg Vogel to identify specialized metabolites and study their
-
regional and international partner institutions. Deadline for applications is 02 November 2025. Virtual panel interviews take place at the end of January 2026. The programme starts in October 2026. The IMPRS
-
with you on board! RESEARCH PROJECT: Prof. Rutsch's research group investigates the molecular basis, pathogenetic principles, and therapeutic options for ectopic calcifications. We are currently looking
-
on board! RESEARCH PROGRAM: The Institute of Medical Biochemistry, headed by Prof. Tim Lämmermann, is part of the Centre of Molecular Biology of Inflammation (ZMBE) and embedded within a vibrant
-
career workshop within the Planck Academy. Further workshops and courses specifically designed for postdocs will be integrated into the program in the medium term. Interested to join us? Your application
-
applicants with purely (bio-)informatics background will not be considered. For inquiries, please contact: Prof. Gerd Meyer zu Hörste, gerd.mzh@uni-muenster.de Apply now via our career portal including CV and
-
oncology trials with special expertise in innovative immunotherapy trials/approaches. He/she should have or develop a broad research program on tools and measures to improve patient access to clinical trials